EDN1 and diabetic kidney disease: (18) Use of endothelin receptor blockers: plasma and urine endothelin-1 levels rise in diabetes and after exposure to high doses of contrast media suggesting a role of endothelin-1 in diabetic nephropathy and in CIN [48, 76].